CCM
Copernicus Capital Management Portfolio holdings
AUM
$8.26M
This Quarter Return
+12.75%
1 Year Return
+37.91%
3 Year Return
+125.34%
5 Year Return
–
10 Year Return
–
AUM
$39M
AUM Growth
+$39M
(-27%)
Cap. Flow
-$19.1M
Cap. Flow
% of AUM
-48.98%
Top 10 Holdings %
Top 10 Hldgs %
88.14%
Holding
18
New
5
Increased
3
Reduced
6
Closed
4
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$4.06M |
| 2 |
UnitedHealth
UNH
|
$2.97M |
| 3 |
IQVIA
IQV
|
$2.88M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$1.74M |
| 5 |
Heron Therapeutics
HRTX
|
$1.05M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
$5.71M |
| 2 |
Merck
MRK
|
$5.23M |
| 3 |
Illumina
ILMN
|
$4.82M |
| 4 |
CVS Health
CVS
|
$3.93M |
| 5 |
Gilead Sciences
GILD
|
$3.77M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Thermo Fisher Scientific
TMO
$183B
| $5.2M | 13.33% |
18,990
-10
| -0.1% | -$2.74K |
|
2
Zoetis
ZTS
$67.6B
| $5.08M | 13.01% |
50,413
+4,974
| +11% | +$501K |
|
|
3
Bristol-Myers Squibb
BMY
$96.5B
| $4.06M | 10.4% |
+85,000
| New | +$4.06M |
|
|
4
Heron Therapeutics
HRTX
$204M
| $3.32M | 8.52% |
135,946
+42,946
| +46% | +$1.05M |
|
5
Vertex Pharmaceuticals
VRTX
$103B
| $3.29M | 8.43% |
17,863
-15,020
| -46% | -$2.76M |
|
|
6
UnitedHealth
UNH
$281B
| $2.97M | 7.61% |
+12,000
| New | +$2.97M |
|
7
Stryker
SYK
$149B
| $2.89M | 7.4% |
14,608
-10,018
| -41% | -$1.98M |
|
|
8
IQVIA
IQV
$31.4B
| $2.88M | 7.38% |
+20,000
| New | +$2.88M |
|
|
9
Gilead Sciences
GILD
$140B
| $2.66M | 6.83% |
40,946
-58,054
| -59% | -$3.77M |
|
10
CareDx
CDNA
$735M
| $2.05M | 5.25% |
64,944
+9,968
| +18% | +$314K |
|
|
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.74M | 4.47% |
+66,000
| New | +$1.74M |
|
|
12
Illumina
ILMN
$15.3B
| $1.65M | 4.24% |
5,320
-15,508
| -74% | -$4.82M |
|
|
13
Intuitive Surgical
ISRG
$167B
| $914K | 2.34% |
1,602
-10,004
| -86% | -$5.71M |
|
|
NVRO
14
DELISTED
NEVRO CORP.
NVRO
| $313K | 0.8% |
+5,000
| New | +$313K |
|
|
15
CVS Health
CVS
$93.5B
| – | – |
-59,956
| Closed | -$3.93M |
|
|
16
Merck
MRK
$212B
| – | – |
-68,461
| Closed | -$5.23M |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| – | – |
-15,000
| Closed | -$2.01M |
|
|
WCG
18
DELISTED
Wellcare Health Plans, Inc.
WCG
| – | – |
-11,500
| Closed | -$2.72M |
|